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Abstract
Lentiviral vectors (LVs) are considered one of the most promising vehicles to efficiently deliver genetic information for basic
research and gene therapy approaches. Combining LVs with drug-inducible expression systems should allow tight control
of transgene expression with minimal side effect on relevant target cells. A new doxycycline-regulated system based on the
original TetR repressor was developed in 1998 as an alternative to the TetR-VP16 chimeras (tTA and rtTA) to avoid secondary
effects due to the expression of transactivator domains. However, previously described TetR-based systems required cell
cloning and/or antibiotic selection of tetracycline-responsive cells in order to achieve good regulation. In the present
manuscript we have constructed a dual Tet-ON system based on two lentiviral vectors, one expressing the TetR through the
spleen focus forming virus (SFFV) promoter (STetR) and a second expressing eGFP through the regulatable CMV-TetO
promoter (CTetOE). Using these vectors we have demonstrated that the TetR repressor, contrary to the reverse
transactivator (rtTA), can be expressed in excess to bind and modulate a high number of TetO operons. We have also
showed that this dual vector system can generate regulatable bulk cell lines (expressing high levels of TetR) that are able to
modulate transgene expression either by varying doxycycline concentration and/or by varying the amount of CTetOE vector
genomes per cell. Based on these results we have developed a new all-in-one lentiviral vector (CEST) driving the expression
of TetR through the SFFV promoter and the expression of eGFP through the doxycycline-responsive CMV-TetO operon. This
vector efficiently produced Tet-ON regulatable immortalized (293T) and primary (human mesenchymal stem cells and
human primary fibroblasts) cells. Bulk doxycycline-responsive cell lines express high levels of the transgene with low
amount of doxycycline and are phenotypically indistinct from its parental cells.
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Introduction
Inducible gene expression systems based on antibiotics or
hormones are a potent research tools and are constantly
developed for their use in basic research and/or clinical
application. Among the existing inducible transcriptional gene
regulatory systems, the reverse Tet transactivator (rtTA)-regula-
table system is the most widely exploited tool for inducible gene
expression. This system, described for the first time by Gossen
and Bujard [1] is based on a chimeric transcription factor (the
tTA transactivator), resulting of the fusion of the bacterial Tet
repressor (TetR) with the activating domain of the herpes virus
simplex viral protein 16 (VP-16). Random mutagenesis of tTA
resulted in the rtTA (reverse tetracycline controlled trans-activator)
protein that, contrary to tTA, requires the tetracycline to bind the
TetO (For review see [2]). The rtTA-based system requires the
addition of tetracycline to activate transcription (TET-ON
system) by allowing the binding of the rtTA to the TetO-CMV
promoter. Several improvements of the rtTA h a v eb e e nd o n et h a t
get better inducibility and reduced background [3,4,5,6].
However, all these tetracycline-inducible systems require a
tetracycline-dependant-transactivator to activate the regulated
promoter. The requirement of a transactivator for transcriptional
activity has several undesired consequences: 1- The regulated
promoters are activated by the transactivator and therefore, its
natural activity can be altered. 2- Binding of the transactivator to
pseudo-TetO sites can activate cellular genes. 3- The presence of a
transactivating domain makes these proteins very toxic [7,8,9,10].
In fact, several studies have demonstrated that the rtTA-based
systems can give rise to data misinterpretation due to the toxicity
of the transactivator [9,10,11].
A new doxycycline-regulated system based on the original TetR
repressor was developed in 1998, by Yao and colleagues [12].
The original TetR do not contain any transactivation domain and
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characteristics should allow the design of a less-toxic Tet-
inducible expression cassette [12] that maintain the endogenous
characteristics of the regulated-promoters and do not transacti-
vate other cellular genes. Using this system, several groups have
achieved good results in terms of low leakiness and high induction
levels [13,14,15,16,17]. However, most of these systems are based
on two vector systems and are reproducible only if the
doxycycline-responsive cells are selected either by cloning
[15,16,18] or antibiotic selection [17]. One of the potential
reasons for this is the high concentrations of TetR required to
block promoter activity [12,19]. In spite of the potential
advantages of the TetR over rtTA to modulate transcription, the
development of regulatable vector systems based on TetR
harbouring all the elements required for doxycycline modulation
(all-in-one vectors) has not been explored in detail. Only three all-
in-one vectors have been described so far, one system based on
herpesvirus simplex (HSV) [19] and two system based on
plasmids and/or lentiviral vectors [17,20]. The use of HSV
based vectors has been mainly limited to neural and cancer cells
due to their tropism and their toxicity.
Lentiviral vectors are one of the most promising vectors for gene
transfer in primary human cells [21,22]. They are highly efficient
and do not express any viral gene that could alter normal cellular
physiology. The generation of a highly efficient lentiviral system
for easy generation of doxycycline-responsive primary cell lines
based on the TetR repressor will certainly be of use not only for
basic research but also for gene therapy applications [23].
Wiederschain at al described recently a useful all-in-one lentiviral
vector able to regulate RNAi. However this system required
selection with antibiotics of the doxycycline-responsive cells [17].
In 2001, Ogueta el al. developed an autoregulatable lentiviral
vector without the requirement of antibiotic selection [20]. This
autoregulatable vector express the TetR repressor through an
internal ribosomal entry site (IRES) located downstream of the
CMVTetO2 promoter. Although this lentiviral system could be of
use for several applications, there have been no further
publications based on this vector module since 2001. In fact, the
same authors observed several potential drawbacks of the system
that could limit the use of the vector: 1- The TetR repressor and
the regulated transgen are expressed through the CMVTetO
promoter. Therefore, the steady-state TetR concentration that is
required to block CMV expression will always allow expression of
the transgene. 2- The efficiency of the IRES (from the EMCV) is
cell-type specific and this can lead to the lost of doxycycline
regulation in important target cells [24].
We have developed a novel two-vector lentiviral system based
on the efficient production of two vectors; one expressing the
TetR repressor through the highly efficient Spleen-Focus-Form-
ing-Virus (SFFV) promoter (STetR vector) and other harbouring
the CMVTetO2 doxycycline-regulated expression cassette driv-
ing eGFP. This dual system allow the easy generation of
doxycycline-regulatable cell lines able to express various amounts
of transgenes by increasing the multiplicity of infection (MOI) of
the regulatable vector. No cloning or antibiotic selection is
required to obtain highly responsive cell lines with this system. In
addition we have combined all the elements required for Tet-ON
regulation into a single lentiviral vector named CEST. CEST
contain the doxycycline-responsive cassette (CMVTetO) driving
the expression of the transgene (eGFP) and the SFFV promoter
expressing high amounts of the TetR protein. This vector
efficiently produced doxycycline-regulated cell lines, including
primary human fibroblasts (HFF) and human mesenchymal stem
cells (hMSCs).
Results
The binary Lentiviral vector system based on the original
TetR repressor achieves high induction and low
background in bulk populations
In order to develop a Tet-ON lentiviral system without
transactivator domains (such as those based on tTA and rtTA)
we used the two expression vectors of the T-Rex Expression
System from Invitrogen (pcDNA4/TO-E and pcDNA/TR,
Invitrogen). We first constructed an alternative two lentiviral
vector system based on pHRSIN-WPRE lentiviral vector [25]
(Figure 1A). The first vector, STetR drives the expression of the
original TetR repressor through the spleen focus forming virus
(SFFV) promoter and the second vector, CTetOE, express eGFP
through the regulatable CMV-TetO promoter (see M&M). The
titre (number of transducing units (tu) per millilitre(ml)) obtained
with both vectors was above 10.000.000 tu/ml before concentra-
tion (data not shown). We used these vectors to generate
doxycycline-regulatable 293 T, K562 and primary human fibro-
blasts (HFF) cell lines. We first transduced the different cell lines
with the STetR vector at a MOI of 10 and 7 days later with the
CTetOE vectors at a MOI of 2. Seven days later, the different cell
lines were incubated in the presence or absence of doxycycline for
48 hours and analyzed for eGFP expression by flow cytometry
(Figure 1B) and fluorescence microscopy (Figure 1C). All cells kept
eGFP expression tightly controlled in the absence of doxycycline
although with significant differences in terms of regulation efficacy.
Tet-ON 293T and HFF cells presented the tightest repression of
eGFP expression in the absence of doxycycline while Tet-ON
K562 cells showed the higher leakiness (eGFP expression levels in
the absence of doxycycline)(Figure 2C).
We next studied the responsiveness of our dual Tet-ON system
to different doxycycline concentrations. Tet-ON HFFs were
incubated with increasing doses of doxycycline, from 0.001 mg/
ml to 0.1 mg/ml, to determine the minimal dose required for
maximal induction. As can be observed in Figure 2, the addition of
0.01 mg/ml of doxycycline was enough to achieved maximal
expression, although 0.001 mg/ml already increased eGFP expres-
sion significantly (Figure 2D). These results showed that the high
titre of the STeR lentiviral vector allowed the easy generation of
stable bulk cell lines, including primary cells, which are highly
responsive to doxycycline after transduction with the regulatable
lentiviral vector CTetOE.
High induction and low leakiness of the TetR-based
system is dependent on high TetR concentration but
independent on CMVTetO target sites
Transactivator-containing repressor (tTA and rtTA) are quite
toxic for most cells and must be kept at low concentration. In
order to achieve good regulation, the concentration of TetO
binding sites must be kept low to equal low transactivator
concentrations[26]. We therefore studied whether this was also
the case for the unmodified TetR-based systems by using STetR
and CTetOE lentiviral vectors. We used increasing amounts of
STetR to obtain 293 T cell lines with increasing amounts of TetR
repressor (Figure 2A; from left to right). All these 293T-TetR
+ cell
lines were transduced with increasing amounts of the CTetOE to
obtain increasing concentrations of CMVTetO targets (Figure 2A:
from top to bottom). We showed that only those cells expressing
high levels of TetR repressor have good induction and low leakiness
(Figure 2A right panels). A minimum of 2 vector genomes per cell
(v.g.c.) of the STetR are required in order to achieve good
regulation and over 3–4 v.g.c. give minimal background and
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there was a direct correlation between the CTetOE v.g.c. and the
fold induction index (Figure 2B). We reached around 1000 fold
induction in bulk populations containing 4–9 v.g.c. of the STetR
vector and 10 v.g.c. of the CTetOE vector (Figure 2A and 2B)
This indicates that the TetR repressor, contrary to the rtTA
transactivator, can be expressed in excess to modulate a high
number of TetO operons. This dual vector system can therefore
generate regulatable cell lines expressing different transgene
amounts by incubating the TetR
+ cells with different amounts of
the regulatable vector (CTetOE) (see Figure 2A right plots, top to
bottom). Each of the different cell lines generated can additionally
be modulated by adjusting doxycycline concentrations (as can be
observed in Figure 1D for HFF cells).
Development of TetR-based all-in-one LV that efficiently
regulates transgene expression
Although a two vector system has several applications in basic
research, single vectors able to deliver the TetR repressor and the
regulatable expression cassette (i.e. CMVTetO) are highly
desirable for the easy generation of doxycycline-responsive
primary cell lines and for gene therapy strategies. We therefore
constructed an all-in-one dual-promoter lentiviral vector named
CEST containing both, the doxycycline-responsive cassette
(CMVTetO) expressing eGFP transgene and the TetR expressing
casset (SFFV-TetR)(Figure 3A). We tested the CEST vector in
immortalized cells (293 T) and primary cells (hMSCs and HFF).
We incubated the different cell lines with increasing MOIs of the
CEST vector. Two weeks later, the different cell lines harbouring
increasing amounts of the CEST vector were analysed for
responsiveness to doxycycline (Figure 3B, only shows for 293 T
cells), leakiness (Figure 3C right graphs) and fold induction index
(Figure 3C, left graphs). Tet-On cells responded to 0.001 mg/ml in
cells harbouring 1–4 v.g.c. of CEST and to 0.01 mg/ml in cells
harbouring 10–20 v.g.c. of CEST (Figure 3B and data not shown).
Interestingly, as occur for the two-vector system, CEST-Tet-ON
cells also requires also several copies of the CEST vector (four or
more v.g.c.) to achieve good regulation (Figure 3B and 3C). To
analyse this results in detail, leakiness and fold induction index of
the different CEST-Tet-ON cell lines were determined and
plotted in function of the amount of integrated CEST vector per
cell. In all cells analysed we found the same results: cells
harbouring the highest amounts of CEST vectors integrated
presented the lowest leakiness (Figure 3C right graphs) and the
highest fold induction index (Figure 3C, left graphs). We reached
up to 400, 180 and 100 fold induction in 293 T (with 20 v.g.c.),
HFF (with 10 v.g.c.) and hMSCs (with 2 v.g.c.) respectively. These
data corroborate the hypothesis that high concentrations of the
TetR repressor is the main factor required to get good doxycycline
regulation and not the number of TetO target sites. Increased
numbers of TetO targets (up to 20 times in 293 T cells; Figure 2B
and 2C top graphs) do not preclude TetR repression but it does
augment transgene expression and therefore increase total fold
induction. This property allowed us to control transgene
expression not only by adjusting doxycycline concentrations but
also by controlling the MOI used for transduction of the target
Figure 1. TetR-based two-vector system for efficient generation of dose-responsive Tet-On cell lines. A) Maps of the two lentiviral
vectors required for doxycycline-dependant transgene regulation. The TetR repressor is expressed through the constitutive SFFV promoter, highly
active in most cell types, including hematopoietic cells. The second lentiviral vector contain the doxycycline-responsive CMV-TetO promoter(Yao et al.
1998) driving the expression of eGFP. 293T, primary human fibroblasts (HFFs) and K562 cells were co-transduced with STetR and CTetOE lentiviral
vectors at high MOI and analyzed by fluorescence microscopy (B) or flow cytometry (C) in the absence (–Dox) or presence (+Dox) of 10 ng/ml of
doxycycline. D) Doxycycline responsiveness (0.001 mg/ml, 0.01 mg/ml and 0.1 mg/ml as indicated) of the Tet-ON HFF cell line derived by
cotransduction with STetR and CTetOE LVs.
doi:10.1371/journal.pone.0023734.g001
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highest inducibility were always obtained with the highest MOIs.
CEST-transduced-293T, -HEF and -hMSC expression levels go
from a MFI of 179, 260 and 872 in the absence of doxycycline to a
MFI of 47956, 46211 and 20265 in the presence of doxycycline
respectively (Figure 3B and data not shown).
The TetR protein efficiently localize to the nucleus
Theoretically, if the amount of TetR repressor expressed by one
copy of the CEST vector is not enough to control one TetO
operon (as demonstrated by the absence of modulation at low
MOI), cells containing multiple copies of the CEST should have
even higher leakiness. One possible explanation could be an
inefficient nuclear transport of the TetR repressor and the
subsequent requirement of hight TetR concentrations in the
cytoplasm to get TetR into the nuclei. To test this hypothesis, we
analysed TetR content in the cytoplasmic and nuclear fractions of
293 T cells transduced at different MOIs. The results showed that
up to 80% of the TetR localize in the nuclei even at low MOI
(Figure 4A; 0.06 v.g.c.). In addition, the percentage of TetR
repressor present in the nuclear versus the cytoplasmic fractions
was very similar independently of the concentration of the TetR
(Figure 4B). These data indicate that TetR is transported to the
nuclei quite efficiently independently of the total TetR cell content.
We further analyzed the level of correlation between eGFP
expression and TetR concentration and/or nuclear localization.
We performed immunostaining of CEST-transduced hMSCs
containing an average of 2 v.g.c. (Figure 4 C). These bulk
CEST-hMSCs contained highly-responsive cells (as observed in
Figure 3C middle graphs and data not shown) but they also
contained a percentage of cells that were inadequately regulated
(cells that are eGFP
+ in the absence of doxycycline). Due to the
low eGFP expression levels of some cells, the pictures taken with
the fluorescence microscopy were further enhanced to visualize
any residual eGFP expression. The aim was to correlate eGFP
expression levels (Figure 4C left panels) with TetR expression
(Figure 4C middle panels). Cells expressing higher amounts of
TetR (white arrows) were completely negative for eGFP expression.
In these cells, a significant part of the TetR was located in the
nuclei as indicated by the purple colour of their nucleus as result of
the co-localization of red (TetR) and blue (DAPI) colours (Figure 4C
white arrows, middle panel). On the contrary, cells expressing
eGFP were negative for TetR expression (Figure 4C, yellow arrows,
middle panel) as demonstrated by the absence of colocalization of
the green and red colours (Figure 4C right panels).
Doxycycline-responsive primary cell lines maintain the
main properties of parental cells
MSCs are an important target for cell-gene therapy applica-
tions. Their role in regeneration, immunomodulation as well as
their migratory capabilities to inflammatory locations makes
them an attractive target for gene manipulation. The develop-
ment of an efficient doxycycline-responsive gene transfer system
to achieve high levels of transgene expression in MSCs (without
affecting its phenotype) is of special interest for the field. We
therefore studied potential changes on doxycycline-responsive
hMSCs compared with parental hMSCs. We compared control
hMSCs (MOCK) with hMSCs containing increasing amounts of
Figure 2. GFP induction level using binary lentiviral vectors. A) 293T cells were stably transduced with increasing amount of STetR lentiviral
vector. Different TetR-expressing 293 T cell lines were generated each harbouring an average of 0.2, 0.8, 2, 4 and 9 vector genomes per cell (v.g.c.)
(indicated on the top of Figure A). Each of these TetR-expressing 293 T cell lines where later transduced with increasing amount of CTetOE vectors
(average of 0.5, 3, 6 and 10 v.g.c.)(indicated on the left of Figure A). Plots show eGFP expression of the different cell lines in the absence (-Dox) or
presence (+Dox) of 1 mg of doxycycline. B). Graph showing the increment in fold induction of transduced 293 T cells after the addition of 100 ng/ml
of doxycycline. The highest induction levels are achieved when the cells contain multiple copies of both StetR (7-9 v.g.c.) and CTetOE vectors (6–10
v.g.c.).
doi:10.1371/journal.pone.0023734.g002
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expression of positive (CD73, CD90, CD105, CD166) and
negative (CD19, CD34, CD45, and HLA-DR) surface markers.
We also studied potential alteration in proliferation and/or
apoptosis in hMSCs containing 2 v.g.c. by analyzing cell cycle
status with Propidium Iodide. We did not detect any changes on
neither the expression of the main surface markers (Figure 5A)
nor in the cell cycle status (Figure 5B).
Another important characteristic of MSCs is their ability to
differentiate toward different cell types. We therefore studied
whether vector transduction affect the ability of MSCs to
differentiate to adipocytes, osteocytes and chondriocytes. As can
be observed in Figure 5C, neither CE (expressing only eGFP) nor
CEST (expressing eGFP and TetR) transduction of MSCs had any
detectable impact on the differentiation potential of MSCs.
Discussion
In the present work we have developed a TetR-based dual and
all-in-one lentiviral system that efficiently generate doxycycline-
responsive cell lines without the requirements of cloning and/or
antibiotic selection. Most of the doxycycline-responsive systems are
based on the TetR-VP16 chymeras (tTA and rtTA) [2,3,4,5,6]. In
these systems, the promoter is only active when the tTA or the
rtTA transactivators bind the regulated promoter. The expression
of the VP16 transactivators in the regulated cells can have several
Figure 3. Easy generation of highly responsive cell lines with the all-in-one doxycline-controlable lentiviral vector CEST. A).
Schematic representation of the CEST. eGFP transgene is expressed from a Tetracycline –responsive CMV-TetO promoter and the TetR repressor is
expressed from the SFFV promoter. B) Doxycycline responsiveness of 293 T containing different amounts of CEST vector copy per cell (0 (Mock), 0.4, 4
and 20 v.g.c. as indicated on the left hand side). The different cell lines were incubated in the absence of doxycycline (-Dox), and with 0.001 mg/ml,
0.01 mg /ml and 0.1 mg /ml as indicated on the top. The leaking in the absence of doxycycline decrease as the vector copy number increase (left
graphs from top to bottom) C) Fold induction (left panels) and leaking (right panels) in 293 T (top panels) and human mesenchymal stem cells
(hMSC) (bottom panels) transduced with increasing MOIs of the CEST vector. The average CEST v.g.c. of the different cell lines analyzed are indicated
at the bottom of the graphs. The best regulation in terms of higher inducibility and lower leaking is achieved in the cells that contain the highest
number of CEST vector integrated.
doi:10.1371/journal.pone.0023734.g003
Figure 4. Nuclear localization of TetR repressor in CEST-transduced cells correlates with complete repression of CMV promoter. A).
Quantitative Western blot analysis showing TetR expression in cytoplasmic and nuclear fraction of 293 T cells transduced with increasing CEST MOIs.
Cell fractionation was carried out as indicated in M&M. ORC2 and GRB2 were used as markers for the nuclear and cytoplasmic fraction respectively,
and as a loading control. B). Graph showing percentage of TetR repressor that is present in the cytoplasmic (gray bars) and nuclear (black bars)
fractions as determined by densitometry analysis of the Western blot (A). Note that the TetR protein is mainly localized within the nucleus,
independently of the TetR concentration. C). Immunofluorescence staining of TetR in CEST transduced hMSCs (2 v.g.c.). Cells were fixed and
incubated with monoclonal IgG1 against TetR amino acid 84-98 and incubated with DAPI (marking nuclei in blue) as indicated in M&M. Left panel
shows a picture that has been manually enhanced to visualize minimally expressed eGFP. Middle and right pictures show TetR expression and eGFP/
TetR merge images respectively. White arrows indicate cells which are completely negative for eGFP expression. Note the purple colour of these cells
(middle and right panels) as consequence of the co-localization of DAPI (Blue) and red (TetR). Yellow arrows indicates cell expressing low levels of TetR
repressor and, therefore expressing eGFP (left and right panels). The nuclei of these cells are intense blue (middle panel) indicating the absence of
TetR expression. v.g.c.; vector genomes per cell. NT; not transduced.
doi:10.1371/journal.pone.0023734.g004
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activity, activation of cellular genes and toxicity [7,8,9,10,11]. We
based our studies in a new doxycycline-regulated system based on
the original TetR repressor developed in 1998 by Yao et al. [12] as
an alternative to the TetR-VP16 chimeras (tTA and rtTA).
We first developed two lentiviral vectors; one driving the
expression of the original TetR repressor through the SFFV
promoter (STetR) and a second one harbouring the CMVTetO
cassette expressing eGFP. We used the SFFV promoter to drive
TetR expression for its well-known characteristic as a strong
promoter in several cell types, including important targets for gene
therapy [25,27,28]. The STetR lentiviral vector was used to
generate different cell lines expressing variable levels of TetR
repressor by increasing the MOI. These cell lines allowed us to
study the minimal requirement of TetR concentration needed for
the regulation of the CMVTetO operon. Previous studies are
somehow contradictory regarding the TetR repressor concentra-
tions required to achieve tetracycline regulation. While Yao et al.
propose that TetR concentration must be kept high to obtain good
tetracycline responsiveness[12,19], other authors argue that
minimal amounts of TetR could be sufficient to shut off the
TetO-regulatable CMV promoter[20]. The fact that most (if not
all) recent publications using the TetR repressor system required
cloning selection or antibiotic selection [15,16,17,18] to generate
regulatable cell lines favour the theory of Yao et al. In this
direction we have done a systematic study demonstrating that in
order to achieve good inducibility and low leakiness, the cells must
contain al least 2 copies of the StetR vector integrated. For
maximal responsiveness, the cells must have over 4 vectors
genomes of STetR per cell that, as shown by Western blot analysis
(Figure 4B), produce very high concentrations of TetR repressor.
The different TetR-293T cell lines were further used to study if
the TetO concentrations are a limiting factor as occur for the rtTA
system. Transactivator-containing repressors (rtTA) are quite toxic
for most of the cells and must be kept at a low concentration.
Therefore, the concentration of TetO binding sites must be kept
low to equal low repressor concentrations[7,11,26]. Contrary to
rtTA-based systems, TetR concentrations inside the regulated cells
were able to modulate high amounts of TetO sequences (present in
the CTetOE vector). Since the leaking was similar in cells
harbouring increasing copies of the CTetOE (in cells harbouring
over 4 StetR v.g.c.) and the expression levels in the presence of
doxycycline augmented proportionally to the amount of CTetOE
v.g.c, the final fold induction index was always better for cells
containing multiple copies of the CTetOE vector. This vector
module can therefore be used to generate regulatable cell lines
expressing increasing amount of the transgene simply by
increasing the MOI of the CTetOE vector. Each of the different
cell lines generated can additionally be modulated by adjusting
doxycycline concentrations.
Although a two vector system has important applications both
in basic research and cell-gene therapy therapeutic approaches,
the availability of all-in-one vector harbouring all the necessary
elements to regulate a transgene is highly desirable for several
applications including in vivo application and the generation of
regulatable human primary cells. All-in-one vectors have the
additional advantage of minimising the amount of integrative
vectors required for transgene modulation and therefore reduce
Figure 5. Doxycycline-responsive human mesenchymal stem cells (hMSCs) maintain the main properties of parental hMSCs. A)
Different doxycycline-responsive hMSCs were generated with increasing MOIs of the CEST vector to obtain an average of 0.1, 0.5, and 2 v.g.c.
(indicated on the top). Expression of the different surface markers were analyzed by flow cytometry and compared to the expression by a parental
(MOCK-transduced) hMSCs. The hMSCs containing 2 v.g.c. of the CEST vector was further analyzed to test the influence of vector expression on cell
cycle status B) and on differentiation potential toward adipogenesis (top panels), osteogenesis (middle) and chondriogenesis (bottom panles) C). No
significant differences were observed between the parental and the CEST-transduced hMSCs.
doi:10.1371/journal.pone.0023734.g005
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generated an all-in-one TetR-based lentiviral vector (CEST)
module for the generation of immortalized and primary human
doxycycline-responsive cell lines. The CEST vector produce over
10.000.000 tu/ml and one transduction with concentrated vector
were able to generate highly-responsive immortalized (293T) and
primary (hMSCs and HEF) cells.
The necessity of multiple copies of the CEST vector to regulate
the transgene confirm the requirement of high levels of the TetR
repressor and, at the same time, also confirms that once this levels
are achieved, they can modulate high amounts of CMVTeO
expression cassettes. Indeed, in CEST-transduced cells, the cells
expressing higher levels of TetR repressor have also higher levels of
CMVTetO to regulate. Still the leakiness drop and the fold
induction increased proportionally to CEST vector genomes per
cell (Figure 3). These data support the hypothesis that high
concentrations of the TetR repressor is the main factor required to
get good doxycycline regulation. In fact increasing the numbers of
TetO targets up to 20 times with the CEST do not preclude
significantly TetR repression but it does augment transgene
expression and therefore increase total fold induction. This
property allowed us to control transgene expression not only by
adjusting doxycycline concentrations but also by controlling the
MOI used for transduction of the target cells. We also showed that
the system is highly responsive to low doses of doxycycline with
1 ng/ml being sufficient to reach peak expression in cells
containing up to 4 v.g.c. However in cell lines with very high
amounts of CEST vector integrated (20 v.g.c.), the maximum
inducibility was achieved with 10 ng/ml of doxycycline. The fact
that high MOIs of the CEST showed lower leakiness than low
MOIs was surprising and probably reflects some way of TetR
cooperation to achieve promoter shut down. We have shown that
in 293 T and MSCs, the TetR repressor is transported inside the
nucleus quite efficiently (up to 80% of the total cell content) and
independently of the TetR concentration eliminating the possibility
of TetR cooperation to reach the nucleus as a factor involved in this
phenomenon. Therefore, we favour the hypothesis of a require-
ment of high concentration of TetR to cooperate for the formation
of TetR homodimers required for promoter shut down. At low
MOIs, the TetR concentration does not reach the minimum
required and are therefore unable to modulate transgene
expression.
An important factor related to the use of the original TetR
repressor is the absence of toxic effects. We analyzed the potential
alteration of TetR overexpression in hMSC, an important target
for cell-gene therapy applications because of its role in regener-
ation and immunomodulation. We did not found any alteration on
the phenotype, cell cycle status or differentiation potential on
hMSCs that were transduced at high MOI with the CEST vector
and that were highly-responsive to doxycycline. However, the fold
induction index of the CEST-transduced MSCs was slightly lower
than CEST-transduced 293 T and HEF cells, probably due to the
differences in CEST vector genome per cell achieved (293 T and
HEF cells are 8–4 times more permissive than hMSCs).
Although both, the dual (StetR and CTetOE) and the all-in-
one-based (CEST) vectors described in this manuscript, are highly
efficient for the development of doxycycline-regulated cell lines,
the requirement of multiple v.g.c. to achieve regulation is an
important drawback of the system. Indeed multiple integrations
are more likely to alter physiology of the doxycycline-regulated
cells and the system work poorly in highly restrictive cells such as
CD34+ cells (data not shown). The ideal vector should allow
complete CMVTetO promoter inhibition with only one vector
integration. We are at the moment trying to improve the system by
comparing various nuclear localization signals on the TetR
repressor, by insulating the all-in one vector and by using alternate
vector modules to increase TetR production. We have evidences
that different cell lines behave differently in term of nuclear
localization of the original TetR and that these differences correlate
with differences in doxycycline regulation (our unpublished data).
Therefore, the use of nuclear localization signal together with
further improvements in the vector should improve not only the
amount of cell lines that can be modulated but also will open the
window to its use for in vivo applications.
Materials and Methods
Cells and reagents
293 T cells (Chantret et al. 1994) were maintained in Dulbecco’s
Modified Eagle’s Medium (DMEM, Invitrogen) supplemented
with 10% Fetal Bovine Serum (FBS, Invitrogen), 1% essential
amino-acids and antibiotics. Human mesenchymal stem cells
(hMSCs) were obtained from Inbiobank (www.inbiobank.org; San
Sebastian, Spain), and were cultured in Advanced-DMEM (Gibco)
plus 10% FBS. When cell cultures achieved over 85% of density,
adherent cells were trypsinized, washed in PBS and re-plated at a
concentration of 5610
3 cells/cm
2. HFFs were purchased from
ATCC (SCD-1112SK). During routine maintenance, HFFs were
grown in IMDM, plus 10% FCS and 2 mM L-glutamine and split
in the ratio 1:2 when they reached 80-90% confluence. K562 were
obtained from the ATCC (CCL-243) and maintained in RPMI
media (Invitrogen), supplemented with 10% Fetal Bovine Serum
(Invitrogen).
Plasmids construction
Dual system. StetR and CTetOE. The StetR vector plasmid
was obtained by replacing EGFP cDNA from the pHRSIN-CSEW
[25] plasmid (using BamHI and NotI excision) with a TetR cDNA
obtained by PCRusingpcDNA6TR (Invitrogene) asa template and
the BamH1-TetR Fw (59 GGATCCATGTCTAGATTAGATA-
AAAG) and Not-TetR reverse (59 GCGGCCGCTTAATAAGAT-
CTGAATTCCCGGG). Primers to include the BamHI NotI sites
at both ends. To construct the CTetOE vector plasmid, we used
pHRSIN-CSEW vector as backbone, excising the SFFV promoter
using EcoRI/BamHI restriction enzymes. A PCR fragment
containing CMVTetO cassette was obtained by PCR using the
EcoR1 forward (CCGGAATTCGTTGACATTGATTATTGA-
CTA) and BamH1 reverse (CGCGGATCCCGGAAGATGGAT-
CGGTCC) primers and the pcDNA4/TO plasmid (Invitrogene) as
template.
All-in-one CEST lentiviral vector. The CEST vector
plasmid harbouring the CMV-TetO regulatable cassette driving
the expression of GFP as well as the spleen focus-forming virus
promoter driving the expression of the TetR repressor gene was
constructed by cloning the SFFV-TetR PstI fragment from the
STetR vector into the unique Pst1 restriction site of the CTetOE
vector.
Vector production and titration
The HIV packing plasmid (pCMVDR 8.9) and VSG-G plasmid
(pMD.G) are described elsewhere (Naldini et al., 1996; Zufferey
et al., 1998). Vector production was performed as described
previously (Toscano et al., 2004). Briefly, 293 T cells, were plated,
and the vector, packaging, and envelope plasmids (plasmid
proportion 3:2:1) were resuspended in 1.5 ml of Opti-MEM
(GIBCO) mixed with 60 ml of Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) and diluted in 1.5 ml of Opti-MEM (GIBCO). The
mixture was added to the 293 T cells, which were incubated for 6–
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were collected and filtered through a 0.45 mm (pore size) filter
(Nalgene, Rochester, NY) aliquoted and immediately frozen at
280uC. For the titration of vectors, transduced cells were lysed
and DNA extracted after 7–10 days, and vector copy number per
genome (v.c.g) was determined using quantitative PCR as
described below.
DNA extraction and quantitative real-time PCR
Genomic DNA was isolated by adding 1 ml per 10
6 cells of SNET
extraction buffer (20 mM Tris-HCl [pH 8], 5 mM EDTA [pH 8],
400 mM NaCl, 1% SDS) containing proteinase K (100 mg/ml;
Sigma- Aldrich). DNA samples were incubated at 55uCf o r2h r ,
proteinase K was inactivated by incubating at 98uC for 10 min, and
RNase (1 mg/ml) was finally added for 30 min at 37uC. Proteins
were extracted twice with phenol–chloroform, and DNA was then
precipitated and its concentration determined by spectrophotometry.
Quantitative real-time PCR were performed with an Mx3005P
system (Agilent). The real time PCRs were performed using the
QuantiTect
TM SYBR Green PCR Kit (from Qiagen). To quantitate
CEST lentiviral integration we used primers for the WPRE sequence;
WPRE-F: 59- CACCACCTGTCAGCTCCTTT and WPRE-R: 59-
ACAACACCACGGAATTGTCA. For the STetR vector we used
primers for TetR sequence, TetR–F: 59 GGGATCCTAGTGAT-
TATGTCT and TetR-R: 59 TTACGGGTTGTTAAACCTTC
and for the CTetOE vector we used primers for the eGFP sequence,
GFP-F: 59GTTCATCTGCACCACCGGCAAG and GFP-R
TTCGGGCATGGCGGACTTGA. The parameters for the PCR
were 16(95uC, 2 min); 406(95uC, 15 sec / 55uC, 30 sec / 72uC,
30 sec); 16(72uC 2 min). We calculated the vector copy number per
genome by interpolation in the standard curve made with 10-fold
increasing amounts of plasmid DNA (CTetOE)) from 10
3 to 10
7
v.g.c. and by starting with 0.6 mg genomic DNA (about 100.000
genomes).
Cell extraction and Western blotting.
Cytosolic and nuclear fractions of transduced and controls cells
were obtained using the Qproteome nuclear protein Kit (Qiagen)
following the manufacturer’s instruction. Proteins were resolved by
sodium dodecyl sulfate– polyacrylamide gel electrophoresis (SDS–
PAGE; 10% polyacrylamide gels, reducing conditions), and
electrotransferred to Hybond-P polyvinylidene difluoride (PVDF)
membranes (GE Healthcare Life Sciences, Buckinghamshire,
UK). Membranes were blocked with 5% nonfat milk and probed
for 1 hr at room temperature with rabbit anti-GRB2 (BD
pharmingen; no 559266), rabbit anti-ORC (BD Pharmigen, no
559166) and mouse anti-Tet-repressor (Mobitec; no TET02).
Combination of IRDye 680LT Goat anti-Rabbit IgG (Licors: no
26-68021) and IRDye 800CW Goat anti-Mouse IgG (Licors: no
926-32210) were use at 1:10.000 dilutions to analyzed TetR protein
in combination with either ORC or GRB2. After washing the
membranes, detection and quantification of protein were per-
formed using Odyssey Image Scanner System (Licor Biosciences,
Cambridge, UK) using IRdye-conjugated secondary antibodies
(Licor) and the Odyssey quantification software.
Inmunostaining
For immunofluorescence analysis of cultured cells, cells were
fixed in 4% paraformaldehyde-PBS for 20 min, permeabilized
with 0.1–1% Triton X-100-PBS for 15 min, and blocked with 5%
PBS for 45 min at room temperature (RT). Fixed cells were
incubated with 2 mg/ml anti-Tet-repressor (Mobitec; TET02) and
then with a secondary Texas-red-conjugated anti-mouse IgG
(Becton Dickinson (BD)). Stained cells were then mounted in
Vectashield mounting medium with DAPI (H-1500, vector
laboratories) to stain the nuclei and examined using an Olympus
AX60 fluorescence microscope.
Phenotype of hMSCs
MSCs were collected, washed and pre-incubated in a PBS-
blocking solution containing 3% of fetal bovine serum (FBS) and
0,2% sodium azide for 15 minutes at 4uC. The following antibodies
were used to fully characterize expression pattern of transduced and
untransduced MSCs: anti human CD90-FITC, CD73-PE, CD105-
FITC, CD166-PE, CD106-PE, CD45-PerCP, CD34-APC, HLA-
DR- PerCP, CD19-APC all from Becton Dickinson (BD).
Antibodies were diluted in PBS 0,3% of FBS and 0,02% sodium
azide. Cells were incubated with 100 ml of the different antibodies
(1/100), for 1 h at 4uC and agitation and washed in PBS 0,3% of
FBSand0,02% sodiumazide followed bya finalwashinPBSalone.
Cells were analyzed on FACS Canto Flow Cytometer.
Adipocyte, Osteocyte and chondriocyte differentiation
Differentiation potential of hMSCs was studied by incubating the
different cell lines in specific differentiation inductive media (Lonza,
Basel, Switzerland). For adipogenicdifferentiation, cellswere cultured
in Adipogenic MSCs differentiation BulletKit (Lonza, Basel,
Switzerland) and stained with Oil Red O (Amresco, Solon, OH).
For osteogenic differentiation, cells were cultured in Osteogenic
MSCs differentiation BulletKit (Lonza, Basel, Switzerland) and
stained with Alizarin Red S (Sigma). For chondrogenic differentia-
tion, cells were cultured in chondrogenic MSCs differentiation
BulletKit(Lonza,Basel,Switzerland),differentiated cellswere include
in paraffin block, and chondrocyte-like cells were inmunodetected
with Anti-S100 (Dako, polyclonal rabbit anti-S100, code Z0311).
Fold induction index and leakiness determination.
Transduced cells incubated in the presence or absence of
different concentrations of doxycycline were analyzed by flow
cytometry to determine the percentage of eGFP positive cells and
the Mean fluorescence intensity (MFI) of either, the eGFP+
population or the entire population.
The Fold induction index was estimated as arbitrary units obtained
by following formula:
[% eGFP
+ (+Dox) / %eGFP
+(-Dox)] x [MFI eGFP
+ cells
(+Dox) / MFI eGFP
+ cells (-Dox)]
Leakiness of the system was determined by using the following
formula:
[% eGFP
+ (-Dox) / %eGFP
+(+Dox)] x MFI eGFP
+ cells (-Dox)
Cell cycle analysis
Cell cycle assays were performed as previously described[29].
Briefly, the trypsinized cells were fixed in 70% ethanol, washed
with PBS, and then incubated with Propidium Iodide (20 mg/ml)
in PBS containing RNase A for 30 min at 37
aC. After washing,
cells were analyzed by flow cytometry (FACS Canto, Becton
Dickenson).
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